Harmony Biosciences Holdings, Inc.

From Harmony Biosciences's results release of 4 de novembro de 2026; its quarterly report has since been filed.

• Revenue

  Actual

  US$ 268,9M

  +12% y/y ↑
  +2,9% q/q ↑

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  US$ 0,81

  -6,9% y/y ↓
  -37% q/q ↓

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  US$ 54,2M

  -17% y/y ↓
  -39% q/q ↓

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.